Journal profile · Biochemistry, Genetics and Molecular Biology-Biochemistry, Genetics and Molecular Biology (miscellaneous)
JIMD Reports
ISSN 2192-8304 · eISSN 2192-8312 · Wiley · United Kingdom
JIMD Reports: CAS Zone 4 · Medicine (2026 Xinrui edition); impact factor 1.6 (journal website); fully open access; APC about USD 2,200; median 111 days to acceptance (90 articles, last 24 months); acceptance rate 48% (journal website); 78 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
JIMD Reports is published by Wiley and is classed under Medicine in the CAS Journal Ranking. By OpenAlex counts of its recent articles, its largest topics are Metabolism and Genetic Disorders, Lysosomal Storage Disorders Research and Mitochondrial Function and Pathology, together about 42.1% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
JIMD Reports is the official open access journal of the Society for the Study of Inborn Errors of Metabolism (SSIEM). Alongside its sister title, Journal of Inherited Metabolic Disease (JIMD), it aims to improve the management and understanding of inherited metabolic disorders throughout the world. JIMD Reports welcomes scientifically sound research findings or clinical observations, whether submitted directly or by referral from JIMD. All articles accepted by JIMD Reports are made freely available to read, download and share immediately on publication. All articles published in JIMD Reports are fully open access: immediately made freely available to read, download, and share. The Society for the Study of Inborn Errors of Metabolism (SSIEM) may cover the APC for corresponding authors who are personal (non-corporate) SSIEM members, but only if they have no other source of funding. (Full details see Instructions for submission or Open Access and SSIEM Member Waivers) Indexing Information Biological Abstracts (Clarivate Analytics) BIOSIS Previews (Clarivate Analytics) Directory of Open Access Journals (DOAJ) Embase (Elsevier) Emerging Sources Citation Index (Clarivate Analytics) OneFile: Health and Medicine (GALE Cengage) OneFile: Nursing and Allied Health (GALE Cengage) PubMed (NLM) SCOPUS (Elsevier) Web of Science (Clarivate Analytics)
From the journal's Aims & Scope
Research area (LetPub): Biochemistry, Genetics and Molecular Biology-Biochemistry, Genetics and Molecular Biology (miscellaneous)
Editor-in-chief Matthias R. BaumgartnerPublisher website
Editorial board by country: none in mainland China; most named United States 9, United Kingdom 7, Germany 7, Netherlands 7, Switzerland 6 (54 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Metabolism and Genetic DisordersBiochemistry, Genetics and Molecular Biology23%
- Lysosomal Storage Disorders ResearchMedicine11.1%
- Mitochondrial Function and PathologyBiochemistry, Genetics and Molecular Biology8%
- Folate and B Vitamins ResearchMedicine6.2%
- Glycogen Storage Diseases and MyoclonusMedicine6%
- Amino Acid Enzymes and MetabolismBiochemistry, Genetics and Molecular Biology4.5%
- Neonatal Health and BiochemistryMedicine4.5%
- Diet and metabolism studiesMedicine4.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Endocrinology & Metabolism | Zone 4 |
| Minor | Genetics & Heredity | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of SciencePubMedEmbasePublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 1.6Publisher website ·
- Impact factor (publisher) 2025
- 1.6Publisher website ·
- CiteScore 2026-06
- 3.3LetPub ·
- CiteScore (publisher)
- 3.3Publisher website ·
- CiteScore (publisher) 2025
- 3.3Publisher website ·
- SJR 2026-06
- 0.53LetPub ·
- SNIP 2026-06
- 0.8LetPub ·
- h-index
- 46OpenAlex ·
- i10-index
- 700OpenAlex ·
- 2-year mean citedness
- 0.81OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 98.87%LetPub ·
Volume
- Articles per year
- 64LetPub ·
- Articles per year (publisher) 2025
- 64Publisher website ·
- Downloads per year (publisher) 2025
- 127,858Publisher website ·
Articles by year OpenAlex count · 1,427 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 69 | 69 | 10 |
| 2025 | 78 | 78 | 45 |
| 2024 | 62 | 62 | 115 |
| 2023 | 58 | 58 | 233 |
| 2022 | 94 | 94 | 690 |
| 2021 | 81 | 81 | 551 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
111 daysMedian, submission to acceptance · P25–P75 78 days – 160 days
- Acceptance to online
- median 21 days (90 articles)
- Submission to online
- median 146 days
- Sample
- 90 articles with submission and acceptance dates (147 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 12 weeksLetPub ·
- Acceptance rate (publisher)
- 48%Publisher website ·
- Acceptance rate (publisher) 2025
- 48%Publisher website ·
- Submission to first decision
- 22 daysPublisher website ·
- Submission to first decision 2025
- 22 daysPublisher website ·
- Submission to acceptance 2025
- 117 daysPublisher website ·
- Acceptance to publication 2025
- 20 daysPublisher website ·
- Submission to publication (journal-reported)
- about 12 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 2,200 / GBP 1,650 / EUR 1,860 | Yes | CC BY | |
| OpenAlex | USD 2,200 / EUR 1,860 / GBP 1,650 | — | — | |
| LetPub | USD 2,000 / GBP 1,496 / EUR 1,693 | Yes | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted8
- case reportSubmissions may take the form of Research Reports, with content similar to that of original articles, Case Reports, Images in Metabolic Medicine or Letters to t…Length not stated
- case reportsCase Reports will only be considered when they highlight some unusual or previously unrecorded feature relevant to the disorder or serve as an important reminde…Length not stated
- images in metabolic medicineImages in Metabolic Medicine should share clinical experience on unique, unexpected clinical findings, for better understanding of IEM.Length not stated
- letterSubmissions may take the form of Research Reports, with content similar to that of original articles, Case Reports, Images in Metabolic Medicine or Letters to t…Length not stated
- letters to the editorsLetters to the Editors may also be used to report exceptionally important clinical or research observations unrelated to a previous JIMD Reports publication tha…Length not stated
- original articleSubmissions may take the form of Research Reports, with content similar to that of original articles, Case Reports, Images in Metabolic Medicine or Letters to t…Length not stated
- research reportSubmissions may take the form of Research Reports, with content similar to that of original articles, Case Reports, Images in Metabolic Medicine or Letters to t…Length not stated
- research reportsSubmissions may take the form of Research Reports, with content similar to that of original articles, Case Reports, Images in Metabolic Medicine or Letters to t…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Publication ethics, Open access
- AI use Artificial Intelligence Generated Content
Authors must disclose any use of generative AI in scientific writing at submission. This applies only to the writing process, not to AI used for data analysis or research. Generative AI may only be used to improve readability and language. Authors must review and edit all AI-generated content, as it may be inaccurate, incomplete, or biased. Authors remain fully responsible for the manuscript. AI t…
Source ↗Publisher website ·- Authorship
Authorship changes allowed with valid reason Model summary
JIMD Reports will allow authors to correct authorship on a submitted, accepted, or published article if a valid reason exists to do so.
Source ↗Publisher website ·- Publication ethics
Patient consent required for case reports, series, images, videos Model summary
Authors must obtain signed patient consent prior to submission for all case reports, case series, clinical images, and clinical videos.
Source ↗Publisher website ·- Open access Open Access and SSIEM Member Waivers
JIMD Reports publishes scientifically sound research findings or clinical observations that warrant communication in the peer-reviewed literature but are of more limited interest to the readers. JIMD Reports is the official open access journal of the Society for the Study of Inborn Errors of Metabolism (SSIEM). The SSIEM may cover the Article Publication Charge (APC) for corresponding authors who …
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 2192-8304
- Electronic ISSN
- 2192-8312
- Latest issue on the website
- Volume 67, Issue 5 (September 2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about JIMD Reports
What CAS zone is JIMD Reports in?
In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of JIMD Reports?
The journal's website gives an impact factor of 1.6 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 3.3, h-index 46.
How long does peer review take at JIMD Reports?
Based on the dates recorded on 90 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 111 days (interquartile range 78–160 days); authors report an average review time of about 12 weeks; the journal's website gives an acceptance rate of 48% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of JIMD Reports based?
Of the 54 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (9), United Kingdom (7) and Germany (7). Counted from the institutions listed on the board page; for reference only.
Which databases index JIMD Reports?
According to LetPub and DOAJ records, JIMD Reports is indexed in ESCI, Scopus and DOAJ. The journal's website also lists Web of Science, PubMed and Embase; that list has not been checked against each database.
Is JIMD Reports open access, and what is the APC?
JIMD Reports is a fully open-access journal. APC about USD 2,200.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .